The treatment of Alcoholism & Palmar Psoriasis with vitamins

Alcoholism and Palmar Psoriasis: Mitamins custom make quality formulas for the treatment of Alcoholism & Palmar Psoriasis with vitamins. A Alcoholism & Palmar Psoriasis formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Alcoholism and Palmar Psoriasis

  • Amount Per Serving
    % DV
    Vitamin A
    5000
    IU
    100%
    Vitamin C
    500
    mg
    833%
    Vitamin D
    200
    IU
    50%
    Vitamin E
    200
    IU
    667%
    Folate
    400
    mcg
    100%
    Magnesium
    150
    mg
    38%
    Zinc
    10
    mg
    67%
    Copper
    1
    mg
    50%
  • Amount Per Serving
    % DV
    Lactobacillus acidolphilus
    100
    mg
    *
    Omega - 3 Fatty Acids
    1000
    mg
    *
    5-HTP
    50
    mg
    *
    Milk Thistle Extract
    50
    mg
    *
    L-Carnitine
    250
    mg
    *
    L-Glutamine
    200
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Alcoholism and Palmar Psoriasis
Serving Size:4-5

Alcoholism and Palmar Psoriasis Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Alnylam And Medtronic Advance Collaboration On Drug-Device Combinations With RNAi Therapeutics For CNS Diseases
Medtronic, Inc., (NYSE: MDT) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced that the companies are advancing their collaboration initiated in February, 2005, following positive pre-clinical data generated under the initial joint technology development phase of the program. Under the terms of the agreement, Alnylam and Medtronic will focus on developing a drug-device combination for the treatment of Huntington's disease.
FAQ When Considering Colorectal Cancer Screening Test
Results from two studies comparing colorectal cancer screening by conventional or optical colonoscopy versus CT colonography have sparked interest in colorectal cancer screening and may raise questions in the minds of consumers.
This information concerning the support of Alcoholism and Palmar Psoriasis treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments